Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of dapagliflozin + saxagliptin to revert from standard basal-bolus insulin therapy
2015-005740-34Phase 4Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin and saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by University Hospital Tübingen. Started Sep 2016; status: terminated.
02
Drugs
dapagliflozinsaxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005740-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005740-34.